Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00451620 | Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes | PHASE2 | COMPLETED | 30 | — | — | Nov 1, 2003 | Sep 1, 2011 | Jan 18, 2018 | 1 | Canada |
| Arm | Type | Description |
|---|---|---|
| 2. | EXPERIMENTAL | GlucoNorm |
| 1. | EXPERIMENTAL | Glyburide |
| Name | Type | Description |
|---|---|---|
| glyburide | DRUG | Subjects will undergo 2 Standard Meal Tests with Ensure 325 ml separated by 15 - 30 days. Group 1 will receive GlucoNorm 1 mg during the 1st Standard Meal Test and Glyburide 2.5 mg during the 2nd Standard Meal Test. Group 2 will receive Glyburide 2.5 mg during the 1st Standard Meal Test and GlucoNorm 1mg during the 2nd Standard Meal Test. |
| GlucoNorm | DRUG | Subjects will undergo 2 Standard Meal Tests with Ensure 325 ml separated by 15 - 30 days. Group 1 will receive GlucoNorm 1 mg during the 1st Standard Meal Test and Glyburide 2.5 mg during the 2nd Standard Meal Test. Group 2 will receive Glyburide 2.5 mg during the 1st Standard Meal Test and GlucoNorm 1mg during the 2nd Standard Meal Test. |
Inclusion Criteria: * Type 2 diabetes \> 3 months duration * Male or female * Over 65 years of age * Diet controlled only * HgbA1C \< 8.5% Exclusion Criteria: * Treatment with oral hypoglycemic agents or insulin or the likelihood of requiring treatment with these during the study. * Anemia - hgb ...